Guideline review reveals widespread controversy over congenital heart disease indications in prenatal care, highlighting the need for international consensus.
Areas of controversy regarding which CHD risk factors warrant FE were greater in quantity than were the areas of consensus. An internationally standardized agreement would be valuable for physicians and guideline developers. For many risk factors, further evidence is needed to justify their use as an indication for FE.
No takes yet. Share an insight, caveat, or question.
Robertis et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Ultrasound in Obstetrics and Gynecology